| abstract |
The invention discloses a pharmaceutical composition, which comprises a pharmacological active substance and a pharmaceutically acceptable carrier, wherein the pharmacological active substance is a compound IV. The dosage form of the pharmaceutical composition is preferably spray or aerosol, and in vitro experiments show that the pharmaceutical composition has higher activity and better antiviral effect. The pharmaceutical composition is low in preparation cost, simple in preparation method, suitable for scale-up production and convenient for later clinical popularization and application. And the medicament adopts a spray or aerosol dosage form, has high dispersity and quick absorption. And the medicament has convenient administration and quick response, and has better application prospect on relevant diseases caused by coronavirus, HIV virus, HPV virus, BV and the like. |